Aspira Women's Health Inc. has announced a delay in filing its Quarterly Report on Form 10-Q for the financial period ended March 31, 2025. The company cited the need for additional time to complete accounting and disclosures related to certain debt and equity transactions. Aspira expects to file the report within a five-day extension period.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Aspira Women's Health Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001641172-25-011022), on May 15, 2025, and is solely responsible for the information contained therein.